- Home
- JAZZ vs GTLS Comparison
JAZZ vs GTLS Comparison
Compare JAZZ & GTLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAZZ
- GTLS
- Stock Information
- Founded
- JAZZ 2003
- GTLS 1859
- Country
- JAZZ Ireland
- GTLS United States
- Employees
- JAZZ N/A
- GTLS N/A
- Industry
- JAZZ Biotechnology: Pharmaceutical Preparations
- GTLS Metal Fabrications
- Sector
- JAZZ Health Care
- GTLS Industrials
- Exchange
- JAZZ Nasdaq
- GTLS Nasdaq
- Market Cap
- JAZZ 7.7B
- GTLS 9.0B
- IPO Year
- JAZZ 2007
- GTLS 1992
- Fundamental
- Price
- JAZZ $126.54
- GTLS $199.38
- Analyst Decision
- JAZZ Strong Buy
- GTLS Buy
- Analyst Count
- JAZZ 14
- GTLS 14
- Target Price
- JAZZ $178.93
- GTLS $200.50
- AVG Volume (30 Days)
- JAZZ 691.3K
- GTLS 1.5M
- Earning Date
- JAZZ 11-05-2025
- GTLS 10-31-2025
- Dividend Yield
- JAZZ N/A
- GTLS N/A
- EPS Growth
- JAZZ N/A
- GTLS 176.90
- EPS
- JAZZ N/A
- GTLS 5.39
- Revenue
- JAZZ $4,086,695,000.00
- GTLS $4,253,100,000.00
- Revenue This Year
- JAZZ $5.65
- GTLS $12.49
- Revenue Next Year
- JAZZ $5.79
- GTLS $9.94
- P/E Ratio
- JAZZ N/A
- GTLS $37.00
- Revenue Growth
- JAZZ 4.52
- GTLS 8.95
- 52 Week Low
- JAZZ $95.49
- GTLS $104.60
- 52 Week High
- JAZZ $148.06
- GTLS $220.03
- Technical
- Relative Strength Index (RSI)
- JAZZ 56.53
- GTLS 65.06
- Support Level
- JAZZ $123.88
- GTLS $198.71
- Resistance Level
- JAZZ $129.50
- GTLS $200.00
- Average True Range (ATR)
- JAZZ 3.03
- GTLS 0.70
- MACD
- JAZZ -0.63
- GTLS -0.78
- Stochastic Oscillator
- JAZZ 29.24
- GTLS 69.46
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
About GTLS Chart Industries Inc.
Chart Industries provides a variety of cryogenic equipment for storage, distribution, and other processes within the industrial gas and liquefied natural gas industries. It also provides natural gas processing solutions for the natural gas industry and specialty products that serve a variety of spaces, including hydrogen, biofuels, cannabis, and water treatment. The firm acquired Howden in a significant deal in early 2023, roughly doubling the size of the company. It plans to merge with Flowserve by the end of 2025.